How Melanocortin Peptides in Your Brain Connect Weight Gain and Depression
The brain's melanocortin peptide system — which controls appetite through POMC, AgRP, and neuropeptide Y — also regulates mood, potentially explaining why obesity and depression so often go hand in hand.
Quick Facts
What This Study Found
The central melanocortin system — a brain circuitry driven by POMC, AgRP, and neuropeptide Y peptides acting on melanocortin receptors — plays a dual role in regulating both feeding behavior and mood. This shared circuitry may explain why obesity and depression so often co-occur.
The review highlights that DSM-5 recognizes two depression subtypes with opposite metabolic profiles: melancholic depression (decreased appetite, weight loss) and atypical depression (hyperphagia, weight gain, fatigue). Melanocortin signaling appears to be involved in both patterns, suggesting it acts as a biological bridge between metabolic state and emotional regulation.
Key Numbers
Review article — synthesizes evidence across human and animal model studies
How They Did This
This is a narrative review examining the published literature on the melanocortin system's role in feeding and mood regulation, drawing from both human clinical data and animal model research. The authors synthesized evidence on POMC, AgRP, neuropeptide Y, and melanocortin receptors (MC3R, MC4R) across behavioral, metabolic, and psychiatric domains.
Why This Research Matters
Depression and obesity affect hundreds of millions of people worldwide and frequently overlap in the same patients. Understanding that shared peptide signaling circuits drive both conditions could lead to treatments that address metabolism and mood simultaneously, rather than treating each in isolation.
The Bigger Picture
The melanocortin system is already a drug target — MC4R mutations cause severe obesity, and melanocortin-based drugs like setmelanotide treat rare genetic obesity. This review adds a psychiatric dimension, suggesting that melanocortin-targeting therapies could have mood effects (positive or negative) and that future drugs might be designed to address the metabolism-mood axis simultaneously. It also contextualizes why GLP-1 drugs, which interact with overlapping brain circuits, appear to affect mood and addictive behaviors.
What This Study Doesn't Tell Us
As a narrative review, this paper synthesizes existing findings rather than presenting new experimental data. The melanocortin circuits linking mood and feeding are not yet fully mapped, and much of the evidence comes from animal models that may not directly translate to humans. The review acknowledges that the system's complexity means current understanding is incomplete.
Questions This Raises
- ?Could melanocortin receptor-targeting drugs be developed that treat both obesity and depression simultaneously?
- ?Do existing weight-loss drugs that affect brain appetite circuits (like GLP-1 agonists) also modulate melanocortin signaling and mood?
- ?Why do some depressed patients lose weight while others gain it — is the melanocortin system wired differently in each subtype?
Trust & Context
- Key Stat:
- 2 depression subtypes DSM-5 defines melancholic (weight loss) and atypical (weight gain) depression — both may involve melanocortin signaling
- Evidence Grade:
- As a narrative review in Biological Psychiatry (a top-tier psychiatric journal), this paper provides a well-sourced synthesis of existing evidence but does not contribute new experimental data. The melanocortin-mood connection is supported by animal studies but needs more human clinical validation.
- Study Age:
- Published in 2022, this review reflects current understanding of melanocortin neuroscience and is highly relevant to ongoing research on peptide-based treatments for metabolic and mood disorders.
- Original Title:
- Melanocortin Signaling Connecting Systemic Metabolism With Mood Disorders.
- Published In:
- Biological psychiatry, 91(10), 879-887 (2022)
- Authors:
- Copperi, Francesca, Kim, Jung Dae, Diano, Sabrina(3)
- Database ID:
- RPEP-06060
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is the melanocortin system and what does it do?
The melanocortin system is a network of neurons in the brain that produce specific peptides — POMC, AgRP, and neuropeptide Y — and their receptors (MC3R, MC4R). It's best known for controlling appetite and energy balance, but this review shows it also influences mood, anxiety, and depression-related behaviors.
Why do obesity and depression so often occur together?
This review suggests that shared brain circuits — particularly the melanocortin peptide system — regulate both feeding behavior and emotional state. When these circuits malfunction, they may simultaneously drive disordered eating and depressed mood, explaining why the two conditions frequently co-occur.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06060APA
Copperi, Francesca; Kim, Jung Dae; Diano, Sabrina. (2022). Melanocortin Signaling Connecting Systemic Metabolism With Mood Disorders.. Biological psychiatry, 91(10), 879-887. https://doi.org/10.1016/j.biopsych.2021.05.026
MLA
Copperi, Francesca, et al. "Melanocortin Signaling Connecting Systemic Metabolism With Mood Disorders.." Biological psychiatry, 2022. https://doi.org/10.1016/j.biopsych.2021.05.026
RethinkPeptides
RethinkPeptides Research Database. "Melanocortin Signaling Connecting Systemic Metabolism With M..." RPEP-06060. Retrieved from https://rethinkpeptides.com/research/copperi-2022-melanocortin-signaling-connecting-systemic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.